Delivery Order SPE2DB22D3301-SPE2DB25FX6FL
Award Date
11/27/24
Potential Completion Date
11/29/24
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,667.52, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,257.04, is for the delivery of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML" and has a completion date of April 15, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,841.24, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a medical product used in healthcare. The contract has a period of performance through February 20, 2025 and was awarded on February 19, 2025. This award is not associated with a set-aside program. The contract is part of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,616.87 Firm Fixed Price Delivery Order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,163.28, is for the supply of 4567969215 ! KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,100.48 firm-fixed-price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award, valued at $1,399.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,071.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply KONVOMEP 2-84 MG/ML oral suspension (90 ml). This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.29 firm fixed-price delivery order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of...